Birdwatch Note
2024-08-17 20:22:51 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Important Context: In 2019, Kamala Harris stated that if a pharmaceutical company used taxpayer funds for research and development and if that company wouldn’t set drug prices to a fair market value, she would fight to remove their patent. https://www.c-span.org/video/?466668-1/kamala-harris-meets-voters-muscatine-iowa
Written by 378ECB71AA43E43F584171A25FEDA0739C89E510584E4F747A980E659E899253
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1824661827156107676
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1824904748379595006
- noteId - 1824904748379595006
- participantId -
- noteAuthorParticipantId - 378ECB71AA43E43F584171A25FEDA0739C89E510584E4F747A980E659E899253
- createdAtMillis - 1723926171761
- tweetId - 1824661827156107676
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 1
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Important Context: In 2019, Kamala Harris stated that if a pharmaceutical company used taxpayer funds for research and development and if that company wouldn’t set drug prices to a fair market value, she would fight to remove their patent. https://www.c-span.org/video/?466668-1/kamala-harris-meets-voters-muscatine-iowa
Note Ratings
| rated at | rated by | |
| 2024-08-24 17:02:13 -0500 | Rating Details | |
| 2024-08-19 10:49:20 -0500 | Rating Details | |
| 2024-08-18 14:13:07 -0500 | Rating Details | |
| 2024-08-18 13:21:30 -0500 | Rating Details | |
| 2024-08-18 12:54:42 -0500 | Rating Details | |
| 2024-08-18 12:09:12 -0500 | Rating Details | |
| 2024-08-18 10:56:09 -0500 | Rating Details | |
| 2024-08-18 08:07:59 -0500 | Rating Details | |
| 2024-08-18 06:37:20 -0500 | Rating Details | |
| 2024-08-18 04:38:45 -0500 | Rating Details | |
| 2024-08-18 03:04:41 -0500 | Rating Details | |
| 2024-08-17 22:14:38 -0500 | Rating Details | |
| 2024-08-17 21:33:22 -0500 | Rating Details | |
| 2024-08-17 21:26:35 -0500 | Rating Details | |
| 2024-08-17 20:34:35 -0500 | Rating Details | |
| 2024-08-17 19:08:29 -0500 | Rating Details | |
| 2024-08-17 18:15:05 -0500 | Rating Details | |
| 2024-08-17 17:38:07 -0500 | Rating Details | |
| 2024-08-17 17:16:08 -0500 | Rating Details | |
| 2024-08-17 16:44:09 -0500 | Rating Details | |
| 2024-08-17 16:39:33 -0500 | Rating Details | |
| 2024-08-17 16:28:19 -0500 | Rating Details | |
| 2024-08-17 16:08:20 -0500 | Rating Details | |
| 2024-08-17 16:00:18 -0500 | Rating Details | |
| 2024-08-17 15:57:04 -0500 | Rating Details | |
| 2024-08-17 15:44:43 -0500 | Rating Details | |
| 2024-08-17 15:36:56 -0500 | Rating Details | |
| 2024-08-19 04:50:36 -0500 | Rating Details | |
| 2024-08-18 17:58:26 -0500 | Rating Details | |
| 2024-08-18 17:12:42 -0500 | Rating Details | |
| 2024-08-18 12:13:38 -0500 | Rating Details | |
| 2024-08-18 11:49:14 -0500 | Rating Details | |
| 2024-08-18 11:38:23 -0500 | Rating Details | |
| 2024-08-18 11:37:59 -0500 | Rating Details | |
| 2024-08-18 09:11:33 -0500 | Rating Details | |
| 2024-08-18 08:30:00 -0500 | Rating Details | |
| 2024-08-18 02:28:57 -0500 | Rating Details | |
| 2024-08-18 00:03:01 -0500 | Rating Details | |
| 2024-08-17 21:07:55 -0500 | Rating Details | |
| 2024-08-17 21:05:04 -0500 | Rating Details | |
| 2024-08-17 20:51:42 -0500 | Rating Details | |
| 2024-08-17 18:32:38 -0500 | Rating Details | |
| 2024-08-17 18:21:19 -0500 | Rating Details | |
| 2024-08-17 16:54:28 -0500 | Rating Details | |
| 2024-08-17 16:47:37 -0500 | Rating Details |